Total Revenue
Insmed Total Revenue increased by 16.0% to $305.96M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 229.6%, from $92.82M to $305.96M. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 33.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Peer comparison
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.37M | $46.76M | $56.12M | $53.11M | $65.22M | $67.73M | $59.30M | $65.21M | $77.23M | $79.07M | $83.69M | $75.50M | $90.34M | $93.43M | $104.44M | $92.82M | $107.42M | $142.34M | $263.84M | $305.96M |
| QoQ Change | — | +3.1% | +20.0% | -5.4% | +22.8% | +3.8% | -12.4% | +10.0% | +18.4% | +2.4% | +5.8% | -9.8% | +19.7% | +3.4% | +11.8% | -11.1% | +15.7% | +32.5% | +85.4% | +16.0% |
| YoY Change | — | — | — | — | +43.8% | +44.9% | +5.7% | +22.8% | +18.4% | +16.7% | +41.1% | +15.8% | +17.0% | +18.2% | +24.8% | +22.9% | +18.9% | +52.4% | +152.6% | +229.6% |
Product Breakdown
| Segment | Q3 '25 | Q1 '26 |
|---|---|---|
| ARIKAYCE external R&D expenses | $114.29M | $98.11M |
| Total | $142.34M | $305.96M |
Business Segments
| Segment | Q1 '22 | Q2 '22 | Q4 '22 |
|---|---|---|---|
| Reportable Segment | $61.34M | $61.34M | $61.34M |
| Total | $53.11M | $65.22M | $59.30M |
Geographic Breakdown — Europe and rest of world
| Segment | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 |
|---|---|---|---|---|---|---|---|---|
| Europe and rest of world | $2.99M | $3.97M | $3.84M | $4.26M | $5.44M | $5.57M | $6.47M | $8.06M |
| Total | $65.21M | $77.23M | $79.07M | $75.50M | $90.34M | $93.43M | $92.82M | $107.42M |
Europe and rest of world was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Geographic Breakdown — International
| Segment | Q3 '25 | Q1 '26 |
|---|---|---|
| International | $40.31M | $35.90M |
| Total | $142.34M | $305.96M |
Total Revenue at Other Companies
Frequently Asked Questions
- What is Insmed's total revenue?
- Insmed (INSM) reported total revenue of $305.96M in Q1 2026.
- How has Insmed's total revenue changed year-over-year?
- Insmed's total revenue increased by 229.6% year-over-year, from $92.82M to $305.96M.
- What is the long-term trend for Insmed's total revenue?
- Over 4 years (2021 to 2025), Insmed's total revenue has grown at a 33.9% compound annual growth rate (CAGR), from $188.46M to $606.42M.
- What does total revenue mean?
- The total amount of money a company brings in from its primary business activities before any expenses.